Featured on Tampa Bay’s Morning Blend: Understanding Ketamine Therapy and a New Approach to Mental Health Treatment
June 4, 2026


Mental health treatment continues to evolve, giving patients more options than ever before when traditional approaches have not delivered meaningful relief.
Recently featured on Tampa Bay’s Morning Blend, NeuroSpa Mental Health + Wellness shared how ketamine therapy is changing the conversation around mental healthcare and creating new possibilities for patients living with depression, anxiety, trauma-related conditions, and other persistent mental health challenges.
During the segment, NeuroSpa providers Elizabeth Biggins and Amanda Calta discussed what ketamine therapy is, how it differs from traditional treatment approaches, and why integrating therapy into the process can create a more comprehensive path toward healing.
Ketamine has been used safely in medicine since the 1960s. From a psychiatric perspective, it has become one of the most significant developments in mental health treatment in recent decades.
Unlike traditional antidepressants, which often focus on serotonin pathways and may take weeks or months to produce noticeable improvement, ketamine works differently within the brain. This unique mechanism has made it an important option for individuals who continue to experience symptoms despite trying conventional treatments.
Today, ketamine therapy is increasingly being used as an off-label treatment option for individuals experiencing depression, anxiety, and trauma-related symptoms.
One of the most notable differences discussed during the Morning Blend feature was the potential timeline for symptom improvement.
Traditional antidepressant medications can require consistent use over time before benefits become noticeable. Ketamine therapy offers a different treatment experience and, for some patients, symptom improvement may occur more rapidly following treatment.
Because every person’s experience is different, treatment plans are individualized based on symptoms, goals, and clinical evaluation.
Ketamine therapy may be considered for individuals who:
As discussed during the segment, treatment is not designed as a daily medication approach. Patients may complete an initial series of treatments and then work with their provider to determine what ongoing care, if any, may be beneficial.
Some patients may require maintenance sessions over time, while others may experience longer periods without additional treatment.
At NeuroSpa, ketamine therapy is not viewed as a standalone treatment. Therapy is an important part of the process, helping patients make sense of new perspectives and shifts in emotional processing that may emerge during treatment. By creating space for reflection and support, therapy helps translate those experiences into meaningful, lasting change.
This combination of medical treatment and therapeutic support reflects NeuroSpa’s broader approach to mental healthcare: personalized care that brings together traditional and advanced treatment options to support long-term recovery and wellness.
No two mental health journeys are the same. At NeuroSpa Mental Health + Wellness, care plans are designed around each individual’s needs and may include psychiatric evaluation, medication management, therapy services, and advanced treatment options when clinically appropriate.
The goal is not simply symptom management. It is helping patients move toward meaningful improvement and lasting recovery.
To learn more about NeuroSpa Mental Health + Wellness and available treatment options, visit neurospamentalhealth.com.
Regulatory Disclosure: IV ketamine therapy for psychiatric conditions — including treatment-resistant depression, PTSD, OCD, and anxiety — is an off-label use. Ketamine has been in widespread clinical use as an anesthetic since 1970 and carries decades of safety data from operating rooms and emergency departments worldwide. Its application to psychiatric conditions does not carry a specific FDA indication, though it is supported by a substantial and growing body of peer-reviewed clinical research. Off-label prescribing is a common, legal, and well-established practice in medicine and is not the same as experimental use. Treatment outcomes vary by individual. NeuroSpa does not guarantee specific results from any treatment, and no claim on this page should be interpreted as a promise of a particular outcome. All treatment decisions are made collaboratively between the patient and their prescribing psychiatrist after a thorough clinical evaluation. Insurance coverage for IV ketamine varies by carrier and plan. NeuroSpa verifies your benefits, explains what your plan will and will not cover, and provides a written out-of-pocket estimate before any treatment is scheduled. Cash-pay is also available.
The content on this page is for educational purposes only and does not constitute medical advice. It is not intended to replace a consultation with a licensed mental health professional. If you are experiencing a mental health emergency, call 988 (Suicide & Crisis Lifeline) or go to your nearest emergency room.